Liver fat content is associated with elevated serum uric acid in the Chinese middle-aged and elderly populations: Shanghai changfeng study

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Lin, Huandong ^a   Li, Qian ^a   Liu, Xiaojing ^a   Ma, Hui ^a   Xia, Mingfeng ^a   Wang, Dan ^a   Li, Xiaoming ^a   Wu, Jiong ^a   Zhao, Naiqing ^a   Pan, Baishen ^a   Gao, Xin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FAT CONTENT; FEMALE; GLUCOSE BLOOD LEVEL; HEPATIC ATTENUATION RATE; HEPATIC RENAL RATIO; HEPATOBILIARY PARAMETERS; HUMAN; HYPERURICEMIA; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PREVALENCE; QUANTITATIVE ANALYSIS; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ADIPOSE TISSUE; AGING; BLOOD; CHINA; CLINICAL TRIAL; DIAGNOSTIC IMAGING; LIVER; METABOLISM; MULTICENTER STUDY; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY;

ADIPOSE TISSUE; AGED; AGING; CHINA; FEMALE; HUMANS; HYPERURICEMIA; LIVER; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREVALENCE; ULTRASONOGRAPHY; URIC ACID;

EID: 84949008875     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140379     Document Type: Article

References (31)

1. Grayson PC, Kim SY, La Valley M, Choi HK (2011) Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 63:102-110.
2. Wang J, Qin T, Chen J, Li Y, Wang L, et al. (2014) Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies. PLoS One 9: e114259. doi: 10.1371/journal.pone.0114259 PMID: 25437867
3. Li C, Hsieh MC, Chang SJ (2013) Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol 25: 210-216. doi: 10.1097/BOR.0b013e32835d951e PMID: 23370374
4. Grassi D, Ferri L, Desideri G, Di Giosia P, Cheli P, et al. (2013) Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Curr Pharm Des 19: 2432-2438. PMID: 23173592
5. Katsiki N, Papanas N, Fonseca VA, Maltezos E, Mikhailidis DP (2013) Uric acid and diabetes: Is there a link? Curr Pharm Des 19: 4930-4937. PMID: 23278493
6. Richette P, Perez-Ruiz F (2013) Serum uric acid and metabolic risk. Curr Med Res Opin 29 Suppl 3: 9-15. doi: 10.1185/03007995.2013.790801 PMID: 23611367
7. Masarone M, Federico A, Abenavoli L, Loguercio C, Persico M (2014) Non alcoholic fatty liver: epidemiology and natural history. Rev Recent Clin Trials 9:126-133. PMID: 25514916
8. Li Z, Xue J, Chen P, Chen L, Yan S, et al. (2014) Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies. J Gastroenterol Hepatol 29: 42-51. doi: 10.1111/jgh.12428 PMID: 24219010
9. Strauss S, Gavish E, Gottlieb P, Katsnelson L(2007) Interobserverand intraobserver variability in the sonographic assessment of fatty liver. AJRAm J Roentgenol 189: W320-323. PMID: 18029843
10. Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, et al. (2009) Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 51:1061-1067. doi: 10.1016/j. jhep.2009.09.001 PMID: 19846234
11. Sertoglu E, Ercin CN, Celebi G, Gurel H, Kayadibi H, et al. (2014) The relationship of serum uric acid with non-alcoholic fatty liver disease. Clin Biochem 47: 383-388. doi: 10.1016/j.clinbiochem.2014.01. 029 PMID: 24525254
12. Xia MF, Yan HM, He WY, Li XM, Li CL, et al. (2012) Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method. Obesity (Silver Spring) 20: 444-452.
13. Gao X, Hofman A, Hu Y, Lin H, Zhu C, et al. (2010) The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design. Eur J Epidemiol 25: 885-893. doi: 10.1007/s10654-010-9525-6 PMID: 21120588
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470. PMID: 10075613
15. Cai W, Song JM, Zhang B, Sun YP, Yao H, et al. (2014) The prevalence of nonalcoholic fatty liver disease and relationship with serum uric acid level in Uyghur population. Scientific World Journal 2014: 393628. doi: 10.1155/2014/393628 PMID: 24516367
16. Li Y, Xu C, Yu C, Xu L, Miao M (2009) Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol 50:1029-1034. doi: 10.1016/j.jhep.2008.11.021 PMID: 19299029
17. Petta S, Camma C, Cabibi D, Di Marco V, Craxi A (2011) Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 34: 757-766. doi: 10.1111/j.1365-2036.2011.04788.x PMID: 21790685
18. Cai W, Wu X, Zhang B, Miao L, Sun YP, et al. (2013) Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China. Arq Bras Endocrinol Metabol 57: 617-622. PMID: 24343630
19. Yan H, Gao X, Liu M, Gu Q, Gao J (2007) Changes of (5-cell function and insulin sensitivity in subjects with non-alcoholic fatty liver disease and normal glucose regulation. Chin J Endocrinol Metab 23:12-15.
20. Bian H, Lin H, Rao S, Yao X, Zeng M, et al. (2010) Association of liver fat content with insulin resistance and islet (5 cell function in individuals with various statuses of glucose metabolism. Chin J Endocrinol Metab 26: 535-540.
21. Li X, Xia M, Ma H, Hu Y, Yan H, et al. (2013) Liver fat content, evaluated through semi-quantitative ultrasound measurement, is associated with impaired glucose profiles: a community-based study in Chinese. PLoS One 8: e65210. doi: 10.1371/journal.pone.0065210 PMID: 23843938
22. Modan M, Halkin H, Karasik A, Lusky A(1987) Elevated serum uric acid-a facet of hyperinsulinaemia. Diabetologia 30: 713-718. PMID: 3322912
23. Kang DH, Ha SK (2014) Uric Acid Puzzle: Dual Role as Anti-oxidantand Pro-oxidant. Electrolyte Blood Press 12:1-6. doi: 10.5049/EBP.2014.12.1.1 PMID: 25061467
24. Sanyal AJ (2002) AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123: 1705-1725. PMID: 12404245
25. Day CP, Saksena S (2002) Non-alcoholic steatohepatitis: definitions and pathogenesis. J Gastroenterol Hepatol 17 Suppl 3: S377-384. PMID: 12472967
26. Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363:1341-1350. doi: 10.1056/NEJMra0912063 PMID: 20879883
27. Lonardo A, Loria P, Leonardi F, Borsatti A, Neri P, et al. (2002) Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. Dig Liver Dis 34: 204-211. PMID: 11990393
28. Lee JW, Cho YK, Ryan M, Kim H, Lee SW, et al. (2010) Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver 4: 378-383. doi: 10.5009/gnl.2010.4.3.378 PMID: 20981217
29. Xu C, Yu C, Xu L, Miao M, Li Y (2010) High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study. PLoS One 5: e11578. doi: 10.1371/journal.pone. 0011578 PMID: 20644649
30. Xu C, Wan X, Xu L, Weng H, Yan M, et al. (2015) Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds. J Hepatol 62:1412-1419. doi: 10.1016/j.jhep.2015.01. 019 PMID: 25623823
31. Billiet L, Doaty S, Katz JD, Velasquez MT (2014) Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol 2014: 852954. doi: 10.1155/2014/852954 PMID: 24693449